Increased levels of pulmonary vasoconstrictive mediators including endothelin-1 and decreased expression of endothelial nitric oxide synthase and prostacyclin synthase have also been observed in COPD compared to normal patients [12,13,14,15]. The gene discussed is NOS3; the disease is chronic obstructive pulmonary disease.